Q3 FY2021 | Q3 FY2020 | Change | |||
(In millions, except per share amounts and percentages) | |||||
Net sales | $ | 6,196 | $ | 4,395 | 41% |
Gross margin | 47.9 | % | 44.5 | % | 3.4 points |
Operating margin | 32.5 | % | 25.2 | % | 7.3 points |
Net income | $ | 1,716 | $ | 841 | 104% |
Diluted earnings per share | $ | 1.87 | $ | 0.91 | 105% |
Non-GAAP Adjusted Results | |||||
Non-GAAP adjusted gross margin | 48.0 | % | 45.0 | % | 3.0 points |
Non-GAAP adjusted operating margin | 32.7 | % | 26.4 | % | 6.3 points |
Non-GAAP adjusted net income | $ | 1,740 | $ | 976 | 78% |
Non-GAAP adjusted diluted EPS | $ | 1.90 | $ | 1.06 | 79% |
Semiconductor Systems | Q3 FY2021 | Q3 FY2020 | ||
(In millions, except percentages) | ||||
Net sales | $ | 4,454 | $ | 2,916 |
Foundry, logic and other | 63 | % | 55 | % |
DRAM | 20 | % | 22 | % |
Flash memory | 17 | % | 23 | % |
Operating income | $ | 1,785 | $ | 958 |
Operating margin | 40.1 | % | 32.9 | % |
Non-GAAP Adjusted Results | ||||
Non-GAAP adjusted operating income | $ | 1,794 | $ | 982 |
Non-GAAP adjusted operating margin | 40.3 | % | 33.7 | % |
Applied Global Services | Q3 FY2021 | Q3 FY2020 | ||
(In millions, except percentages) | ||||
Net sales | $ | 1,286 | $ | 1,034 |
Operating income | $ | 393 | $ | 273 |
Operating margin | 30.6 | % | 26.4 | % |
Non-GAAP Adjusted Results | ||||
Non-GAAP adjusted operating income | $ | 393 | $ | 277 |
Non-GAAP adjusted operating margin | 30.6 | % | 26.8 | % |
Display and Adjacent Markets | Q3 FY2021 | Q3 FY2020 | ||
(In millions, except percentages) | ||||
Net sales | $ | 431 | $ | 425 |
Operating income | $ | 99 | $ | 83 |
Operating margin | 23.0 | % | 19.5 | % |
Non-GAAP Adjusted Results | ||||
Non-GAAP adjusted operating income | $ | 100 | $ | 87 |
Non-GAAP adjusted operating margin | 23.2 | % | 20.5 | % |
Three Months Ended | Nine Months Ended | |||||||
(In millions, except per share amounts) |
August 1, 2021 |
July 26, 2020 |
August 1, 2021 |
July 26, 2020 | ||||
Net sales | $ | 6,196 | $ | 4,395 | $ | 16,940 | $ | 12,514 |
Cost of products sold | 3,229 | 2,440 | 8,971 | 6,952 | ||||
Gross profit | 2,967 | 1,955 | 7,969 | 5,562 | ||||
Operating expenses: | ||||||||
Research, development and engineering | 640 | 572 | 1,863 | 1,674 | ||||
Marketing and selling | 159 | 130 | 454 | 395 | ||||
General and administrative | 155 | 145 | 465 | 411 | ||||
Severance and related charges | - | - | 158 | - | ||||
Deal termination fee | - | - | 154 | - | ||||
Total operating expenses | 954 | 847 | 3,094 | 2,480 | ||||
Income from operations | 2,013 | 1,108 | 4,875 | 3,082 | ||||
Interest expense | 57 | 61 | 179 | 181 | ||||
Interest and other income, net | 24 | (7) | 69 | 22 | ||||
Income before income taxes | 1,980 | 1,040 | 4,765 | 2,923 | ||||
Provision for income taxes | 264 | 199 | 589 | 435 | ||||
Net income | $ | 1,716 | $ | 841 | $ | 4,176 | $ | 2,488 |
Earnings per share: | ||||||||
Basic | $ | 1.89 | $ | 0.92 | $ | 4.57 | $ | 2.71 |
Diluted | $ | 1.87 | $ | 0.91 | $ | 4.52 | $ | 2.69 |
Weighted average number of shares: | ||||||||
Basic | 908 | 915 | 914 | 916 | ||||
Diluted | 918 | 922 | 923 | 924 |
(In millions) |
August 1, 2021 |
October 25, 2020 | ||
ASSETS | ||||
Current assets: | ||||
Cash and cash equivalents | $ | 6,066 | $ | 5,351 |
Short-term investments | 444 | 387 | ||
Accounts receivable, net | 3,822 | 2,963 | ||
Inventories | 4,117 | 3,904 | ||
Other current assets | 799 | 764 | ||
Total current assets | 15,248 | 13,369 | ||
Long-term investments | 1,658 | 1,538 | ||
Property, plant and equipment, net | 1,814 | 1,604 | ||
Goodwill | 3,479 | 3,466 | ||
Purchased technology and other intangible assets, net | 116 | 153 | ||
Deferred income taxes and other assets | 2,164 | 2,223 | ||
Total assets | $ | 24,479 | $ | 22,353 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||
Current liabilities: | ||||
Accounts payable and accrued expenses | $ | 3,437 | $ | 3,138 |
Contract liabilities | 1,688 | 1,321 | ||
Total current liabilities | 5,125 | 4,459 | ||
Long-term debt, net of current portion | 5,451 | 5,448 | ||
Income taxes payable | 1,144 | 1,206 | ||
Other liabilities | 699 | 662 | ||
Total liabilities | 12,419 | 11,775 | ||
Total stockholders' equity | 12,060 | 10,578 | ||
Total liabilities and stockholders' equity | $ | 24,479 | $ | 22,353 |
(In millions) | Three Months Ended | Nine Months Ended | ||||||
August 1, 2021 |
July 26, 2020 |
August 1, 2021 |
July 26, 2020 | |||||
Cash flows from operating activities: | ||||||||
Net income | $ | 1,716 | $ | 841 | $ | 4,176 | $ | 2,488 |
Adjustments required to reconcile net income to cash provided by operating activities: | ||||||||
Depreciation and amortization | 98 | 94 | 289 | 279 | ||||
Severance and related charges | - | - | 149 | - | ||||
Share-based compensation | 81 | 70 | 272 | 234 | ||||
Deferred income taxes | 20 | 79 | 44 | 98 | ||||
Other | (15) | 33 | (30) | 55 | ||||
Net change in operating assets and liabilities | (214) | (250) | (606) | (665) | ||||
Cash provided by operating activities | 1,686 | 867 | 4,294 | 2,489 | ||||
Cash flows from investing activities: | ||||||||
Capital expenditures | (137) | (87) | (462) | (260) | ||||
Cash paid for acquisitions, net of cash acquired | - | (80) | (12) | (107) | ||||
Proceeds from sales and maturities of investments | 400 | 353 | 1,024 | 1,388 | ||||
Purchases of investments | (457) | (178) | (1,179) | (1,010) | ||||
Cash provided by (used in) investing activities | (194) | 8 | (629) | 11 | ||||
Cash flows from financing activities: | ||||||||
Debt borrowings, net of issuance costs | - | 1,481 | - | 2,979 | ||||
Debt repayments | - | (2,882) | - | (2,882) | ||||
Proceeds from common stock issuances | - | - | 86 | 91 | ||||
Common stock repurchases | (1,500) | (200) | (2,250) | (599) | ||||
Tax withholding payments for vested equity awards | (12) | (3) | (171) | (166) | ||||
Payments of dividends to stockholders | (219) | (202) | (622) | (587) | ||||
Cash used in financing activities | (1,731) | (1,806) | (2,957) | (1,164) | ||||
Increase (decrease) in cash, cash equivalents and restricted cash equivalents | (239) | (931) | 708 | 1,336 | ||||
Cash, cash equivalents and restricted cash equivalents-beginning of period | 6,413 | 5,396 | 5,466 | 3,129 | ||||
Cash, cash equivalents and restricted cash equivalents - end of period | $ | 6,174 | $ | 4,465 | $ | 6,174 | $ | 4,465 |
Reconciliation of cash, cash equivalents, and restricted cash equivalents | ||||||||
Cash and cash equivalents | $ | 6,066 | $ | 4,350 | $ | 6,066 | $ | 4,350 |
Restricted cash equivalents included in deferred income taxes and other assets | 108 | 115 | 108 | 115 | ||||
Total cash, cash equivalents, and restricted cash equivalents | $ | 6,174 | $ | 4,465 | $ | 6,174 | $ | 4,465 |
Supplemental cash flow information: | ||||||||
Cash payments for income taxes | $ | 232 | $ | 238 | $ | 641 | $ | 519 |
Cash refunds from income taxes | $ | 3 | $ | - | $ | 26 | $ | 5 |
Cash payments for interest | $ | 34 | $ | 41 | $ | 137 | $ | 151 |
(In millions) | Q3 FY2021 | Q3 FY2020 | ||
Unallocated net sales | $ | 25 | $ | 20 |
Unallocated cost of products sold and expenses | (208) | (156) | ||
Share-based compensation | (81) | (70) | ||
Total | $ | (264) | $ | (206) |
Q3 FY2021 | Q3 FY2020 | |||
Net Sales by Geography (In millions)
| ||||
United States | $ | 533 | $ | 399 |
% of Total | 9 | % | 9 | % |
Europe | $ | 238 | $ | 196 |
% of Total | 4 | % | 5 | % |
Japan | $ | 449 | $ | 472 |
% of Total | 7 | % | 11 | % |
Korea | $ | 1,291 | $ | 1,051 |
% of Total | 21 | % | 24 | % |
Taiwan | $ | 1,261 | $ | 687 |
% of Total | 20 | % | 16 | % |
Southeast Asia | $ | 173 | $ | 120 |
% of Total | 3 | % | 2 | % |
China | $ | 2,251 | $ | 1,470 |
% of Total | 36 | % | 33 | % |
Employees (In thousands)
| ||||
Regular Full Time | 26.0 | 23.6 |
Three Months Ended | Nine Months Ended | |||||||
(In millions, except percentages) |
August 1, 2021 |
July 26, 2020 |
August 1, 2021 |
July 26, 2020 | ||||
Non-GAAP Adjusted Gross Profit | ||||||||
Reported gross profit - GAAP basis | $ | 2,967 | $ | 1,955 | $ | 7,969 | $ | 5,562 |
Certain items associated with acquisitions1
| 6 | 8 | 21 | 25 | ||||
Certain incremental expenses related to COVID-192
| - | 15 | 12 | 23 | ||||
Other charges
| - | - | 2 | - | ||||
Non-GAAP adjusted gross profit | $ | 2,973 | $ | 1,978 | $ | 8,004 | $ | 5,610 |
Non-GAAP adjusted gross margin | 48.0 | % | 45.0 | % | 47.2 | % | 44.8 | % |
Non-GAAP Adjusted Operating Income | ||||||||
Reported operating income - GAAP basis | $ | 2,013 | $ | 1,108 | $ | 4,875 | $ | 3,082 |
Certain items associated with acquisitions1
| 11 | 12 | 36 | 38 | ||||
Acquisition integration and deal costs | 5 | 20 | 40 | 54 | ||||
Certain incremental expenses related to COVID-192
| - | 20 | 24 | 30 | ||||
Severance and related charges3
| - | - | 158 | - | ||||
Deal termination fee | - | - | 154 | - | ||||
Other charges | - | - | 6 | - | ||||
Non-GAAP adjusted operating income | $ | 2,029 | $ | 1,160 | $ | 5,293 | $ | 3,204 |
Non-GAAP adjusted operating margin | 32.7 | % | 26.4 | % | 31.2 | % | 25.6 | % |
Non-GAAP Adjusted Net Income | ||||||||
Reported net income - GAAP basis | $ | 1,716 | $ | 841 | $ | 4,176 | $ | 2,488 |
Certain items associated with acquisitions1
| 11 | 12 | 36 | 38 | ||||
Acquisition integration and deal costs | 5 | 20 | 41 | 54 | ||||
Certain incremental expenses related to COVID-192
| - | 20 | 24 | 30 | ||||
Severance and related charges3
| - | - | 158 | - | ||||
Deal termination fee | - | - | 154 | - | ||||
Realized loss (gain) on strategic investments, net | (6) | (8) | (2) | (1) | ||||
Unrealized loss (gain) on strategic investments, net | (13) | (5) | (45) | (1) | ||||
Loss on early extinguishment of debt | - | 33 | - | 33 | ||||
Other charges | - | - | 6 | - | ||||
Income tax effect of share-based compensation4
| 11 | 12 | (12) | (13) | ||||
Income tax effects related to intra-entity intangible asset transfers | 23 | 67 | 60 | 104 | ||||
Resolution of prior years' income tax filings and other tax items | (9) | (1) | (22) | (5) | ||||
Income tax effect of non-GAAP adjustments5
| 2 | (15) | (43) | (30) | ||||
Non-GAAP adjusted net income | $ | 1,740 | $ | 976 | $ | 4,531 | $ | 2,697 |
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. |
2 | Temporary incremental employee compensation during the COVID-19 pandemic. |
3 | The severance and related charges primarily related to a one-time voluntary retirement program offered to certain eligible employees. |
4 | GAAP basis tax benefit related to share-based compensation is recognized ratably over the fiscal year on a non-GAAP basis. |
5 | Adjustment to provision for income taxes related to non-GAAP adjustments reflected in income before income taxes. |
Three Months Ended | Nine Months Ended | |||||||
(In millions, except per share amounts) |
August 1, 2021 |
July 26, 2020 |
August 1, 2021 |
July 26, 2020 | ||||
Non-GAAP Adjusted Earnings Per Diluted Share | ||||||||
Reported earnings per diluted share - GAAP basis | $ | 1.87 | $ | 0.91 | $ | 4.52 | $ | 2.69 |
Certain items associated with acquisitions | 0.01 | 0.01 | 0.03 | 0.04 | ||||
Acquisition integration and deal costs | 0.01 | 0.02 | 0.04 | 0.05 | ||||
Certain incremental expenses related to COVID-19 | - | 0.02 | 0.02 | 0.03 | ||||
Loss on early extinguishment of debt
| - | 0.03 | - | 0.03 | ||||
Severance and related charges | - | - | 0.13 | - | ||||
Deal termination fee | - | - | 0.17 | - | ||||
Realized loss (gain) on strategic investments, net | (0.01) | (0.01) | 0.01 | - | ||||
Unrealized loss (gain) on strategic investments, net | (0.01) | - | (0.05) | - | ||||
Other charges | - | - | 0.01 | - | ||||
Income tax effect of share-based compensation | 0.01 | 0.01 | (0.01) | (0.02) | ||||
Income tax effects related to intra-entity intangible asset transfers | 0.03 | 0.07 | 0.06 | 0.11 | ||||
Resolution of prior years' income tax filings and other tax items | (0.01) | - | (0.02) | (0.01) | ||||
Non-GAAP adjusted earnings per diluted share | $ | 1.90 | $ | 1.06 | $ | 4.91 | $ | 2.92 |
Weighted average number of diluted shares | 918 | 922 | 923 | 924 |
Three Months Ended | Nine Months Ended | |||||||
(In millions, except percentages) |
August 1, 2021 |
July 26, 2020 |
August 1, 2021 |
July 26, 2020 | ||||
Semiconductor Systems Non-GAAP Adjusted Operating Income | ||||||||
Reported operating income - GAAP basis | $ | 1,785 | $ | 958 | $ | 4,588 | $ | 2,655 |
Certain items associated with acquisitions1
| 9 | 9 | 29 | 29 | ||||
Acquisition integration costs | - | 1 | (2) | 1 | ||||
Certain incremental expenses related to COVID-192
| - | 14 | 12 | 20 | ||||
Other charges | - | - | 3 | - | ||||
Non-GAAP adjusted operating income | $ | 1,794 | $ | 982 | $ | 4,630 | $ | 2,705 |
Non-GAAP adjusted operating margin | 40.3 | % | 33.7 | % | 38.7 | % | 32.6 | % |
AGS Non-GAAP Adjusted Operating Income | ||||||||
Reported operating income - GAAP basis | $ | 393 | $ | 273 | $ | 1,083 | $ | 807 |
Certain incremental expenses related to COVID-192
| - | 4 | 8 | 8 | ||||
Other charges
| - | - | 1 | - | ||||
Non-GAAP adjusted operating income | $ | 393 | $ | 277 | $ | 1,092 | $ | 815 |
Non-GAAP adjusted operating margin | 30.6 | % | 26.8 | % | 30.0 | % | 26.7 | % |
Display and Adjacent Markets Non-GAAP Adjusted Operating Income | ||||||||
Reported operating income - GAAP basis | $ | 99 | $ | 83 | $ | 229 | $ | 196 |
Certain items associated with acquisitions1
| 1 | 3 | 3 | 9 | ||||
Certain incremental expenses related to COVID-192
| - | 1 | 1 | 1 | ||||
Severance and related charges3
| - | - | 8 | - | ||||
Non-GAAP adjusted operating income | $ | 100 | $ | 87 | $ | 241 | $ | 206 |
Non-GAAP adjusted operating margin | 23.2 | % | 20.5 | % | 19.8 | % | 18.4 | % |
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. |
2 | Temporary incremental employee compensation during the COVID-19 pandemic. |
3 | The severance and related charges related to workforce reduction actions globally across the Display and Adjacent Markets business. |
Three Months Ended | ||
(In millions, except percentages) | August 1, 2021 | |
Provision for income taxes - GAAP basis (a)
| $ | 264 |
Income tax effect of share-based compensation | (11) | |
Income tax effects related to intra-entity intangible asset transfers | (23) | |
Resolutions of prior years' income tax filings and other tax items | 9 | |
Income tax effect of non-GAAP adjustments | (2) | |
Non-GAAP adjusted provision for income taxes (b)
| $ | 237 |
Income before income taxes - GAAP basis (c)
| $ | 1,980 |
Certain items associated with acquisitions | 11 | |
Acquisition integration and deal costs | 5 | |
Realized loss (gain) on strategic investments, net | (6) | |
Unrealized loss (gain) on strategic investments, net | (13) | |
Non-GAAP adjusted income before income taxes (d)
| $ | 1,977 |
Effective income tax rate - GAAP basis (a/c)
| 13.3 | % |
Non-GAAP adjusted effective income tax rate (b/d)
| 12.0 | % |
Attachments
- Original document
- Permalink
Disclaimer
Applied Materials Inc. published this content on 19 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 August 2021 20:13:12 UTC.